查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948399

2026年全球子宫肌瘤栓塞器械市场报告

Uterine Fibroid Embolization Device Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，子宫肌瘤栓塞器械的市场规模持续扩大，预计将从2025年的59.3亿美元成长到2026年的61.9亿美元，复合年增长率（CAGR）为4.4%。过去几年的增长可归因于以下因素：育龄妇女子宫肌瘤患病率的上升、医院和诊所妇科手术数量的增加、介入放射学中子宫动脉栓塞术的日益普及、人们对开放式肌瘤切除术之外的替代治疗方法的认识不断提高，以及三级医疗机构微创治疗流程的扩展。

预计未来几年子宫肌瘤栓塞器械市场将稳定成长，到2030年市场规模将达到73.3亿美元，复合年增长率（CAGR）为4.3%。预测期内的成长要素包括：年轻患者对保留子宫的子宫肌瘤治疗需求不断增长；临床治疗模式向微创和非侵入性治疗模式的转变日益明显；门诊手术中心手术普及率不断提高；消融和栓塞器械在缩小肌瘤方面的应用日益广泛；以及为提高治疗精准度而加大对先进导管输送和栓塞系统的投资。预测期内的主要趋势包括：微创栓塞技术在子宫肌瘤治疗中的应用日益普及；临床上越来越倾向于选择保留器官的治疗方案而非子宫切除术；影像引导介入器械在靶向肌瘤治疗中的应用日益广泛；栓塞术在门诊和日间手术中的广泛应用；以及对精准输送系统以提高手术安全性和疗效的需求不断增长。

微创手术需求的不断增长预计将推动子宫肌瘤栓塞器械市场的成长。微创手术是指透过微小切口或自然腔道进入并治疗器官、组织和结构，同时最大限度地减少患者不适的手术。随着越来越多的患者和医疗机构寻求更短的恢復时间、更低的併发症风险和更高的整体舒适度，此类手术的需求也不断增长。子宫肌瘤栓塞器械透过达到肌瘤的精准有效治疗，改善患者预后并提高手术效率，进而为这些手术提供支持。例如，根据美国医学期刊《AOS Open》的报告，截至2025年1月，在采用机器人辅助系统的医院中，微创手术占所有手术的65.8%，高于2022年的60.5%。因此，对微创手术日益增长的需求正在推动子宫肌瘤栓塞器械市场的发展。

该市场中的企业正致力于研发创新技术，例如微创子宫肌瘤管理软体，以提高子宫肌瘤治疗的精准度和效率。这类软体为临床医师提供先进的数位化工具，辅助其规划、指导和实施微创手术，进而提高手术的准确性、安全性和病患疗效。例如，2024年9月，专注于微创妇科手术的美国医疗设备製造商Gynesonics发布了适用于其Sonata系统的SMART OS 2.4软体。软体将最小消融区域尺寸从2.0 x 1.3厘米缩小至1.6 x 1.2厘米，消融体积减少了38%，并优化了较小子宫肌瘤的热感安全边界。这使得治疗过程更加可控，同时也最大限度地保护了健康的子宫组织。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球子宫肌瘤栓塞器械市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 微创栓塞术在治疗子宫肌瘤的应用日益广泛
    • 临床上越来越倾向选择保留器官而非子宫切除术的替代方案
    • 扩大影像导引介入设备在子宫肌瘤标靶治疗的应用
    • 扩大栓塞术在门诊和日间手术的应用
    • 为提高手术安全性和治疗效果，对精准输送系统的需求日益增长

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 门诊手术中心
  • 专业妇科中心
  • 其他的

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球子宫肌瘤栓塞器械市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球子宫肌瘤栓塞器械市场规模、对比及成长率分析
  • 全球子宫肌瘤栓塞器械市场表现：规模与成长，2020-2025年
  • 全球子宫肌瘤栓塞器械市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 透过技术
  • 外科手术、腹腔镜手术、消融治疗、栓塞术
  • 透过治疗方法
  • 侵入性治疗，微创治疗
  • 最终用户
  • 医院、诊所及门诊手术中心
  • 按类型细分：手术治疗方法
  • 开放性手术，子宫肌瘤切除术
  • 依类型细分：腹腔镜手术技术
  • 腹腔镜子宫肌瘤切除术，腹腔镜子宫切除术
  • 按类型细分：消融技术
  • 射频消融、微波消融、冷冻消融
  • 依类型细分：栓塞
  • 经导管动脉栓塞术（TAE）、子宫动脉栓塞术（UAE）

第十章 区域与国家分析

  • 全球子宫肌瘤栓塞器械市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球子宫肌瘤栓塞器械市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 子宫肌瘤栓塞器械市场：竞争格局及市占率（2024年）
  • 子宫肌瘤栓塞器械市场：公司估值矩阵
  • 子宫肌瘤栓塞器械市场：公司概况
    • Johnson and Johnson Pvt Ltd.
    • Medtronic plc.
    • Boston Scientific Corporation
    • Olympus Corporation
    • Terumo Corporation

第37章：其他领先和创新企业

  • Ethicon Inc., Hologic Inc., CooperSurgical Inc., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年子宫肌瘤栓塞器械市场：提供新机会的国家
  • 2030年子宫肌瘤栓塞器械市场：充满新机会的细分市场
  • 2030年子宫肌瘤栓塞器械市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MUFED01_G26Q1

A uterine fibroid embolization device is a medical device used in the treatment of noncancerous tumors, specifically uterine fibroids, through a minimally invasive procedure. Uterine fibroids are benign growths in the uterus, and this device functions by restricting the blood supply to these fibroids, causing them to shrink and ultimately disappear.

The main types of technologies associated with uterine fibroid embolization devices include surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. Surgical techniques involve specific methods and procedures employed by medical professionals. These devices are utilized in various treatment modes, including invasive, minimally invasive, and non-invasive treatments. Additionally, they find application in diverse healthcare settings such as hospitals, clinics, and ambulatory surgical centers.

Tariffs are impacting the uterine fibroid embolization device market by increasing the import and manufacturing costs of embolic agents, microcatheters, delivery systems, and imaging-guided interventional components, leading to higher procedure costs across hospitals, clinics, and ambulatory surgical centers. The effect is more pronounced in regions relying on cross-border sourcing of interventional radiology devices, particularly in North America, Europe, and Asia-Pacific specialty care markets. Segments such as embolization techniques and minimally invasive treatment systems experience the strongest pricing pressure; however, tariffs are also encouraging domestic assembly, regional supply localization, and innovation in cost-efficient device design, which supports long-term supply resilience and market competitiveness.

The uterine fibroid embolization device market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid embolization device market statistics, including uterine fibroid embolization device industry global market size, regional shares, competitors with a uterine fibroid embolization device market share, detailed uterine fibroid embolization device market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid embolization device industry. This uterine fibroid embolization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroid embolization device market size has grown steadily in recent years. It will grow from $5.93 billion in 2025 to $6.19 billion in 2026 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to rising prevalence of uterine fibroids among women of reproductive age, growing number of hospital and clinic-based gynecological procedures, increasing adoption of uterine artery embolization in interventional radiology, greater awareness of alternatives to open surgical myomectomy, expansion of minimally invasive treatment workflows in tertiary care centers.

The uterine fibroid embolization device market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to rising demand for uterus-sparing fibroid treatments in younger patient populations, growing clinical shift toward minimally invasive and non-invasive treatment modes, increasing procedural penetration in ambulatory surgical centers, expanding use of ablation and embolization devices for fibroid size reduction, rising investments in advanced delivery catheters and embolic systems to improve treatment precision. Major trends in the forecast period include rising adoption of minimally invasive embolization techniques for uterine fibroid treatment, increasing clinical preference for organ-preserving alternatives to hysterectomy, growing utilization of image-guided interventional devices for targeted fibroid therapy, expanding use of embolization procedures in outpatient and ambulatory surgical settings, increasing demand for precision delivery systems to improve procedural safety and outcomes.

The growing demand for minimally invasive surgeries is expected to drive the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve small incisions or the use of natural body openings to access and treat internal organs, tissues, or structures while minimizing trauma to the patient. The demand for these procedures is increasing as patients and healthcare providers seek treatments that reduce recovery time, lower complication risks, and improve overall comfort. Uterine fibroid embolization devices facilitate these procedures by enabling precise and effective treatment of fibroids, improving patient outcomes and procedural efficiency. For instance, in January 2025, according to AOS Open, a US-based medical journal, hospitals with robotic-assisted systems reported that minimally invasive surgeries accounted for 65.8% of procedures in 2025, up from 60.5% in 2022. Therefore, the growing demand for minimally invasive surgeries is propelling the uterine fibroid embolization device market.

Companies in this market are focusing on innovations such as minimally invasive fibroid management software to improve precision and efficiency in uterine fibroid treatment. This type of software provides clinicians with advanced digital tools to plan, guide, and execute minimally invasive procedures, enhancing procedural accuracy, safety, and patient outcomes. For example, in September 2024, Gynesonics, a US-based medical device company specializing in minimally invasive gynecologic treatments, launched SMART OS 2.4 software for the Sonata System. The software reduces the minimum ablation zone size from 2.0 X 1.3 cm to 1.6 X 1.2 cm, decreases ablation volume by 38%, and optimizes the Thermal Safety Border for smaller fibroids, enabling more controlled treatments while preserving healthy uterine tissue.

In October 2024, Hologic Inc., a US-based medical technology company, acquired Gynesonics for $350 million. This acquisition expands Hologic's portfolio of minimally invasive treatment options for women's health, particularly in the management of uterine fibroids and heavy menstrual bleeding. Gynesonics develops minimally invasive solutions for the treatment of symptomatic uterine fibroids, and its integration strengthens Hologic's position in the women's health market.

Major companies operating in the uterine fibroid embolization device market are Johnson and Johnson Pvt Ltd., Medtronic plc., Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Ethicon Inc., Hologic Inc., CooperSurgical Inc., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC

North America was the largest region in the uterine fibroid embolization device market in 2025. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the uterine fibroid embolization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The uterine fibroid embolization device market consists of revenues earned by entities by provide services such as minimally invasive procedures, non-invasive procedures, minimally invasive procedures, radiofrequency ablation, medication and hormonal therapy, and embolization procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The uterine fibroid embolization device market also includes sales of medications, hysteroscopic devices, laparoscopic devices, radiofrequency ablation devices, endometrial ablation devices, hysterectomy devices, and robotic surgical systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroid Embolization Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses uterine fibroid embolization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroid embolization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The uterine fibroid embolization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Surgical Techniques; Laparoscopic Techniques; Ablation Techniques; Embolization Techniques
  • 2) By Mode Of Treatment: Invasive Treatment; Minimally Invasive Treatment
  • 3) By End User: Hospitals; Clinics; Ambulatory Surgical Center
  • Subsegments:
  • 1) By Surgical Techniques: Open Surgery; Myomectomy
  • 2) By Laparoscopic Techniques: Laparoscopic Myomectomy; Laparoscopic Hysterectomy
  • 3) By Ablation Techniques: Radiofrequency Ablation; Microwave Ablation; Cryoablation
  • 4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE); Uterine Artery Embolization (UAE)
  • Companies Mentioned: Johnson and Johnson Pvt Ltd.; Medtronic plc.; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Ethicon Inc.; Hologic Inc.; CooperSurgical Inc.; Cook Medical Inc.; Karl Storz GmbH; Merit Medical Systems; CONMED Corporation; Lumenis Ltd.; Richard Wolf GmbH; BTG International Ltd.; Healthium MedTech Pvt. Ltd.; Hironic Co.Ltd; Minerva Surgical Inc.; Gynesonics Inc.; Advanced Surgical Concepts PLLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Uterine Fibroid Embolization Device Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Uterine Fibroid Embolization Device Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Uterine Fibroid Embolization Device Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Uterine Fibroid Embolization Device Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Minimally Invasive Embolization Techniques For Uterine Fibroid Treatment
    • 4.2.2 Increasing Clinical Preference For Organ-Preserving Alternatives To Hysterectomy
    • 4.2.3 Growing Utilization Of Image-Guided Interventional Devices For Targeted Fibroid Therapy
    • 4.2.4 Expanding Use Of Embolization Procedures In Outpatient And Ambulatory Surgical Settings
    • 4.2.5 Increasing Demand For Precision Delivery Systems To Improve Procedural Safety And Outcomes

5. Uterine Fibroid Embolization Device Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Gynecology Centers
  • 5.5 Others

6. Uterine Fibroid Embolization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Uterine Fibroid Embolization Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Uterine Fibroid Embolization Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Uterine Fibroid Embolization Device Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Uterine Fibroid Embolization Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Uterine Fibroid Embolization Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Uterine Fibroid Embolization Device Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Uterine Fibroid Embolization Device Market Segmentation

  • 9.1. Global Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques
  • 9.2. Global Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Invasive Treatment, Minimally Invasive Treatment
  • 9.3. Global Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Ambulatory Surgical Center
  • 9.4. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Surgical Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Open Surgery, Myomectomy
  • 9.5. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Laparoscopic Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laparoscopic Myomectomy, Laparoscopic Hysterectomy
  • 9.6. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Ablation Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation, Microwave Ablation, Cryoablation
  • 9.7. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Embolization Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcatheter Arterial Embolization (TAE), Uterine Artery Embolization (UAE)

10. Uterine Fibroid Embolization Device Market Regional And Country Analysis

  • 10.1. Global Uterine Fibroid Embolization Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Uterine Fibroid Embolization Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Uterine Fibroid Embolization Device Market

  • 11.1. Asia-Pacific Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Uterine Fibroid Embolization Device Market

  • 12.1. China Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Uterine Fibroid Embolization Device Market

  • 13.1. India Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Uterine Fibroid Embolization Device Market

  • 14.1. Japan Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Uterine Fibroid Embolization Device Market

  • 15.1. Australia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Uterine Fibroid Embolization Device Market

  • 16.1. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Uterine Fibroid Embolization Device Market

  • 17.1. South Korea Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Uterine Fibroid Embolization Device Market

  • 18.1. Taiwan Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Uterine Fibroid Embolization Device Market

  • 19.1. South East Asia Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Uterine Fibroid Embolization Device Market

  • 20.1. Western Europe Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Uterine Fibroid Embolization Device Market

  • 21.1. UK Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Uterine Fibroid Embolization Device Market

  • 22.1. Germany Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Uterine Fibroid Embolization Device Market

  • 23.1. France Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Uterine Fibroid Embolization Device Market

  • 24.1. Italy Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Uterine Fibroid Embolization Device Market

  • 25.1. Spain Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Uterine Fibroid Embolization Device Market

  • 26.1. Eastern Europe Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Uterine Fibroid Embolization Device Market

  • 27.1. Russia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Uterine Fibroid Embolization Device Market

  • 28.1. North America Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Uterine Fibroid Embolization Device Market

  • 29.1. USA Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Uterine Fibroid Embolization Device Market

  • 30.1. Canada Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Uterine Fibroid Embolization Device Market

  • 31.1. South America Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Uterine Fibroid Embolization Device Market

  • 32.1. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Uterine Fibroid Embolization Device Market

  • 33.1. Middle East Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Uterine Fibroid Embolization Device Market

  • 34.1. Africa Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Uterine Fibroid Embolization Device Market Regulatory and Investment Landscape

36. Uterine Fibroid Embolization Device Market Competitive Landscape And Company Profiles

  • 36.1. Uterine Fibroid Embolization Device Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Uterine Fibroid Embolization Device Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Uterine Fibroid Embolization Device Market Company Profiles
    • 36.3.1. Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Uterine Fibroid Embolization Device Market Other Major And Innovative Companies

  • Ethicon Inc., Hologic Inc., CooperSurgical Inc., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC

38. Global Uterine Fibroid Embolization Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Uterine Fibroid Embolization Device Market

40. Uterine Fibroid Embolization Device Market High Potential Countries, Segments and Strategies

  • 40.1 Uterine Fibroid Embolization Device Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Uterine Fibroid Embolization Device Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Uterine Fibroid Embolization Device Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer